Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GLP1 Agonists Once Weekly for the Treatment of Obesity in Patients With Bardet-Biedl Syndrome (BBS)

NCT07602803 is registered in ClinicalTrials.gov with The Queen Elizabeth Hospital as lead sponsor.

NCT NCT07602803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07602803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GLP1 Agonists Once Weekly for the Treatment of Obesity in Patients With Bardet-Biedl Syndrome (BBS)
Lead sponsor
The Queen Elizabeth Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2023
Completion date
April 22, 2026
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bardet-biedl syndrome